Overview |
bsm-52014M |
Alpha-Synuclein (2G5) Monoclonal Antibody |
WB |
Human |
Specifications |
Unconjugated |
Mouse |
Synthetic peptide derived from human Alpha-Synuclein, around 1-30aa. |
Monoclonal |
2G5 |
IgG1 |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide. |
Store at -20°C for 12 months. |
Target |
6622 |
P37840 |
PD1; NACP; PARK1; PARK4; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; SNCA |
May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation. |
Application Dilution |
WB |
1:300-5000 |